Creative Planning Matinas Bio Pharma Holdings, Inc. Transaction History

Creative Planning

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 01, 2019	SELL	$0.53 - $1.11 $107,719 - $225,601	-203,245 Closed	0 $0
Q2 2018 Jul 20, 2018	BUY	$0.42 - $0.74 $85,362 - $150,401	203,245 New	203,245 $88,000
Q4 2017 Jan 17, 2018	SELL	$1.1 - $1.54 $40,975 - $57,365	-37,250 Closed	0 $0
Q3 2017 Oct 17, 2017	BUY	$1.19 - $1.43 $44,327 - $53,267	37,250	37,250 $49,000

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $115M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.